Ginkgo Bioworks Holdings, Inc. — Form 8-K Summary
Business Context and Reporting Period
Ginkgo Bioworks Holdings, Inc. filed this Form 8-K on May 10, 2023, under Items 2.02 and 9.01. The filing relates to the company’s financial results for the first quarter ended March 31, 2023.
Financial Results and Key Metrics
The filing states that Ginkgo issued a press release announcing its first-quarter 2023 financial results. The text provided does not include the accompanying press release or clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The filing text does not provide comparative financial data or describe material changes from the first quarter of 2022.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook commentary, risk disclosures, contingencies, or unusual items. These matters may be addressed in Exhibit 99.1, which is referenced but not included in the supplied text.
Important Facts to Verify
- Review Exhibit 99.1 for the actual first-quarter 2023 financial results and comparative figures.
- Verify revenue, net income or loss, adjusted metrics, operating expenses, cash position, cash burn, and liquidity.
- Check for management guidance, business updates, customer or program metrics, and material risks or contingencies.
- Confirm whether the press release contains non-GAAP measures and reconcile them to the applicable GAAP results.